微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 8.24% | 7.99% | 53.45% | 32/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 5.37% | 2.87% | 103.41% | 30/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.64% | 0% | -74.83% | 38/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 10.49% | 28.71% | 37.48% | 27/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 7.63% | 13.04% | 46.17% | 42/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.22% | 6.1% | 97.73% | 36/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.64% | -1.49% | -67.61% | 45/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 8.15% | -39.41% | 20.74% | 40/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 6.75% | -37.67% | 37.2% | 48/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.92% | -33.87% | 83.58% | 42/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.68% | -13.83% | -80.07% | 45/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 13.45% | -8.44% | 24.19% | 25/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 10.83% | -14.32% | 45.56% | 27/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 7.44% | -31.24% | 139.23% | 23/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.11% | -42.51% | -78.83% | 34/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 14.69% | -45.81% | 16.22% | 20/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 12.64% | 2% | 16.82% | 16/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 10.82% | -31.3% | 100% | 12/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.41% | 2% | -80.04% | 8/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 27.11% | 57.98% | 72.13% | 8/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 15.75% | 2% | -8.22% | 7/158 | 4.23% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-12-31 | 17.16% | 2% | 2% | 24/158 | 2.57% | 河化股份 | 45.32% | 行业排名> |